Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
No Data
ASPN Transcript
Aspen Aerogels, Inc. (ASPN) Q1 2026 Earnings Call Transcript
Unknown5-7
The earnings call reveals several challenges: an 8% revenue decline, operational disruptions, supply chain issues, and market uncertainties, particularly in the EV segment. Despite some improvements in EBITDA and cash reserves, the company's financial performance is weak, with significant net losses and cost pressures. The Q&A session did not provide substantial positive insights to offset these negatives. Given the small-cap nature of the company, these factors suggest a negative stock price movement of -2% to -8% over the next two weeks.
Aspen Aerogels, Inc. (ASPN) Q4 2025 Earnings Call Transcript
Positive2-25
Aspen Aerogels reported strong financial performance with a 25% revenue increase and improved margins, leading to positive net income. The strategic initiatives indicate growth potential, particularly in EV and energy sectors. Risks are acknowledged but typical. No concerning Q&A issues. Market cap suggests moderate stock reaction, predicting a 2% to 8% increase.
Aspen Aerogels, Inc. (ASPN) Q3 2025 Earnings Call Transcript
Unknown11-6
The earnings call reflects mixed sentiments. The basic financial performance shows declining margins and EBITDA, suggesting negative sentiment. However, the company is optimistic about future growth, particularly in the Energy Industrial segment and European OEM contributions. Shareholder return plans were not explicitly mentioned, while lower CapEx and streamlined operations indicate financial prudence. The Q&A highlights management's cautious optimism but also reveals uncertainties, especially regarding GM volumes. Considering the company's market cap, these mixed signals suggest a neutral stock price movement prediction.
Aspen Aerogels, Inc. (ASPN) Presents At Barclays 39th Annual CEO Energy-Power Conference 2025 Transcript
Neutral9-3
ASPN Slides
Aspen Aerogels Q4 2025 slides: European pivot amid 67% revenue drop2026-02-25
Aspen Aerogels Q3 2025 slides: Revenue dips amid EV market reset, cost cuts underway2025-11-06
Aspen Aerogels Q2 2025 slides: EBITDA doubles as cost-cutting takes effect2025-08-07
Aspen Aerogels Q1 2025 slides: $301M impairment charge overshadows cost-cutting progress2025-05-08
ASPN Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
